BBC NEWS Americas Africa Europe Middle East South Asia Asia Pacific Arabic Spanish Russian Chinese Welsh
BBCi CATEGORIES   TV   RADIO   COMMUNICATE   WHERE I LIVE   INDEX    SEARCH 

BBC NEWS
 You are in: Health
Front Page 
World 
UK 
UK Politics 
Business 
Sci/Tech 
Health 
Background Briefings 
Medical notes 
Education 
Entertainment 
Talking Point 
In Depth 
AudioVideo 


Commonwealth Games 2002

BBC Sport

BBC Weather

SERVICES 
Saturday, 8 December, 2001, 00:40 GMT
'Encouraging' malaria vaccine
mosquito
Malaria is transmitted by mosquitoes
Progress may have been made towards a vaccine against one of the biggest killer diseases in the world.

A vaccine for malaria developed in a joint project between the UK and Gambia, so far has only a moderate success rate.

However, its inventors are hopeful the principle can be refined to make it much more effective.

Traditionally, efforts to protect against malaria have met with very little success.

An estimated 2.7m die every year as a result of the disease, which is carried by certain types of mosquito, and common across large swathes of the globe.

The majority of these deaths are among children.

Some protection

It is caused by a parasite which can invade the patient's cells, and which multiplies within the body.

The vaccine aims to prevent the parasite, Plasmodium falciparum, from invading red blood cells, which will prevent it from reaching the part of the body where it reproduces.

A year-long trial of 306 male, adult volunteers found the vaccine, if four doses are given, achieves a 47% effectiveness.

A single dose protected 34% of the the group.

Children next

It will now proceed to bigger trials - the scientists involved are hopeful that it will prove more effective when used on children.

Dr Kalifa Bojang, of the Medical Research Council Laboratories in Banjul, Gambia, said the results were encouraging, showing scientists were on the right track.

"The important thing to bear in mind that this 34% was in adults and the immune response in children might be different," he said.

Trials will now be expanded into Mozambique - and will be tested on children aged between one and five.

The study can be found in The Lancet medical journal.

See also:

31 Dec 00 | Health
Scientists 'block malaria'
15 May 01 | Health
The anti-malaria drug dilemma
Internet links:


The BBC is not responsible for the content of external internet sites

Links to more Health stories are at the foot of the page.


E-mail this story to a friend

Links to more Health stories